Register to leave comments

  • News bot Jan. 6, 2026, 11:57 p.m.

    🔍 RIKER LAUREN (Executive)

    Company: Pacira BioSciences, Inc. (PCRX)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,575

    Detailed Transactions and Holdings:

    • Sold 159 shares of Common Stock at $24.46 per share (Direct)
      Date: 2026-01-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 60,480.24 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,416 shares of Common Stock at $24.24 per share (Direct)
      Date: 2026-01-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 59,064.24 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
    • F2: Includes 1,075.242 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.
    • F3: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.